Unstable immune cells linked to severe cancer immunotherapy side effects
Scientists at the University of Pittsburgh uncovered the unstable immune cells that can cause up to 40% of…
Study explains why cancer immunity declines faster in males
Lutz Menzel, PhD, formerly of the Department of Radiation Oncology within the Mass General Brigham Cancer Institute, and…
New research unveils role of innate immune system in pancreatic cancer
Researchers from Adelaide University have demonstrated that blocking a specific immune system gene can reduce pancreatic cancer tumor…
Rare dendritic cells may promote immune tolerance in metastatic cancer
This study was co-led by Steven Blum, MD. Gary Reynolds, MD, PhD, Samuel Klempner, MD, and Alexandra-Chloé Villani,…
Combination therapy overcomes immunotherapy resistance in glioblastoma
Scientists at The Wistar Institute have identified a combination treatment that overcomes two of the biggest barriers to…
A New Approach to Preventing Bladder Cancer Recurrence
In this interview, News Medical speaks with Professor Govind Srimathveeravalli, Associate Professor of Mechanical and Industrial Engineering at the…
Simple urine test can accurately diagnose and track bladder cancer
A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System…
New mathematical model tracks how tumor environment impacts cancer therapies
Researchers from Mass General Brigham and the University of Cyprus have developed a sophisticated mathematical model to better…
The cellular landscape of druggable RNA-binding proteins
Gerstberger, S., Hafner, M. & Tuschl, T. A census of human RNA-binding proteins. Nat. Rev. Genet. 15, 829–845…
Neuromedin U drives immune suppression in aggressive prostate cancer
A new study from The Wistar Institute has found a link between the nervous system and the rapid…
Study identifies B cells as drivers of immunotherapy-related colitis
Researchers at The University of Texas MD Anderson Cancer Center have identified a previously unknown role for B…
Scientists reveals how cancer-causing p53 mutations remain invisible to the immune system
One of the biggest challenges in cancer immunotherapy may not be that immune cells are too weak, but…